Home / All Reports / TNMM /Research and development (Stem cell) — FY 2023-25
TNMM
Research and development (Stem cell) — FY 2023-25
A TNMM benchmarking study covering Eastern Europe, MENA and Türkiye for FY 2023-25, based on 13 accepted comparables. Benchmark run Aug 2026.
Eastern EuropeMENATürkiyeTNMMFY 2023-257211 - Research and experimental development on biotechnology
| Jurisdiction | Eastern Europe, MENA, Türkiye |
|---|---|
| Method | TNMM |
| Financial Year | FY 2023-25 |
| Industry | 7211 - Research and experimental development on biotechnology |
| Profit level indicator | Net cost plus (NCP) / Operating margin (OM) |
| Net cost plus (NCP) | 13.35% |
| Operating margin (OM) | 11.78% |
| Accepted comparables | 13 |
| Benchmark date | Aug 2026 |
| Report code | SP-12 |
| Last updated | September 2026 |